FDA Decisions and Trade Dynamics

This chapter focuses on the FDA's missed deadline for Novavax's COVID-19 vaccine approval amidst leadership changes and layoffs. It also delves into Trump’s new tariffs and their impact on global trade, exploring industry reactions and potential business strategies in light of evolving market conditions.